Diagnosing and containing sexually transmitted diseases (STDs) remains a worldwide challenge of huge proportions. The Determine® line of rapid in vitro qualitative immunoassays helps professionals to detect STDs -- HIV, hepatitis B, and syphilis – in 15 minutes.

Some 37.8 million people are currently living with HIV; 4.8 million were newly infected in 2003.  With the growing HIV/AIDS epidemic, this simple, rapid Determine® test can help not only in diagnosing individual infection, but also in preventing mother-to-child transmission, monitoring HIV prevalence, and screening blood donations. 

Hepatitis B remains endemic in large portions of the world and continues to cause significant morbidity. 

Syphilis remains a public health threat around the world, and this rapid diagnostic test can play a pivotal role in global efforts to control this disease.  In addition to the inherent risks of morbidity and mortality to infants born to maternal carriers, syphilis also increases, by 2- to 5-fold, a patient’s chance of acquiring HIV infection.  Determine® Syphilis TP is a highly accurate, reliable diagnostic tool for controlling this serious disease—useful for screening pregnant women for congenital syphilis, and for on-site testing of those with suspicious clinical lesions.

The Determine® brand name is the professional’s first choice when it comes to simple, rapid tests for sexually transmitted diseases.

To find out more about Determine® go to www.determinetest.com

Determine® HIV-1/2
Determine® HBsAg
Determine® Syphilis TP